Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells

Journal of Interferon and Cytokine Research

Volumn 29, Issue 3, 2009, Pages 179-192

  Toka, Felix N ^a,b   Nfon, Charles K ^a   Dawson, Harry ^c   Estes, D Mark ^d   Golde, William T ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; PERFORIN; GAMMA INTERFERON; INTERLEUKIN RECEPTOR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TUMOR CELL; ANIMAL; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; DRUG POTENTIATION; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; K562 CELL LINE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

FOOT-AND-MOUTH DISEASE VIRUS; SUS;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DRUG SYNERGISM; FIBROBLASTS; FLOW CYTOMETRY; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-18; K562 CELLS; KILLER CELLS, NATURAL; PERFORIN; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE;

EID: 61749101539     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0058     Document Type: Article

References (47)

1. Alter G, Malenfant JM, Altfeld M. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294(1-2):15-22.
2. Bautista EM, Ferman GS, Golde WT. 2003. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet Immunol Immunopathol 92(1-2):61-73.
3. Bautista EM, Ferman GS, Gregg D, Brum MC, Grubman MJ, Golde WT. 2005. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol 79(8):4838-4847.
4. Bryceson YT, March ME, Ljunggren HG, Long EO. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107(1):159-166.
5. Byrne P, McGuirk P, Todryk S, Mills KH. 2004. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 34(9):2579-2588.
6. Carter QL, Curiel RE. 2005. Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection. Vet Immunol Immunopathol 107(1-2):105-118.
7. Chaudhry UI, Plitas G, Burt BM, Kingham TP, Raab JR, DeMatteo RP. 2007. NK dendritic cells expanded in IL-15 exhibit antitumor responses in vivo. J Immunol 179(7):4654-4660.
8. Clark R, Griff ths GM. 2003. Lytic granules, secretory lysosomes and disease. Curr Opin Immunol 15(5):516-521.
9. Denyer MS, Wileman TE, Stirling CM, Zuber B, Takamatsu HH. 2006. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Vet Immunol Immunopathol 110(3-4):279-292.
10. Derbyshire JB, Lesnick CE. 1990. Hyporeactivity to interferon induction in newborn piglets. J Interferon Res 10(1):47-53.
11. Duchene DA, Gallagher BL, Ratliff TL, Winfield HN. 2008. Systemic and cell-specific immune response to laparoscopic and open nephrectomy in porcine model. J Endourol 22(1):113-120.
12. Endsley JJ, Endsley MA, Estes DM. 2006. Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. J Leukocyte Biol 79(1):71-79.
13. Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, French AR, Ley TJ. 2007. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26(6):798-811.
14. Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, Wynn TA, Sher A. 2006. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol 177(10):7086-7093.
15. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147(3):874-882.
16. Gill N, Ashkar AA. 2007. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15. Eur J Immunol 37(9):2529-2538.
17. Golde WT, Pacheco JM, Duque H, Doel T, Penfold B, Ferman GS, Gregg DR, Rodriguez LL. 2005. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. Vaccine 23(50):5775-5782.
18. Golden-Mason L, Kelly AM, Doherty DG, Traynor O, McEntee G, Kelly J, Hegarty JE, O'Farrelly C. 2004. Hepatic interleuklin 15 (IL-15) expression: implications for local NK/NKT cell homeostasis and development. Clin Exp Immunol 138(1): 94-101.
19. Granucci F, Zanoni I, Pavelka N, Van Dommelen SL, Andoniou CE, Belardelli F, Degli Esposti MA, Ricciardi-Castagnoli P. 2004. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 200(3):287-295.
20. Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ. 2004. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104(9):2840-2848.
21. Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T. 2002. Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis. Int Immunopharmacol 2(4):423-434.
22. Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 70(8):5282-5287.
23. Klein E, Vanky F, Masucci MG, Bejarano MT. 1984. Experimental and clinical data for the role of NK-cells in immunosurveillance. Behring Inst Mitt (74):140-148.
24. Knoblock KF, Canning PC. 1992. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4. Immunology 76(2):299-304.
25. Kobayashi T. 1989. [Role of NK cells in lung metastasis immunosurveillance]. Gan To Kagaku Ryoho 16(4 Pt 2-1):1233-1245.
26. Lanier LL. 2005. NK Cell Recognition. Ann Rev Immunol 23(1):225-274.
27. Lauwerys BR, Garot N, Renauld JC, Houssiau FA. 2000. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J Immunol 165(4):1847-1853.
28. Liu CC, Perussia B, Young JD. 2000. The emerging role of IL-15 in NK-cell development. Immunol Today 21(3):113-116.
29. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5(12):1260-1265.
30. Mason PW, Piccone ME, McKenna TS, Chinsangaram J, Grubman MJ. 1997. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227(1):96-102.
31. Miyaji C, Watanabe H, Miyakawa R, Yokoyama H, Tsukada C, Ishimoto Y, Miyazawa S, Abo T. 2002. Identification of effector cells for TNFalpha-mediated cytotoxicity against WEHI164S cells. Cell Immunol 216(1-2):43-49.
32. Montoya CJ, Velilla PA, Chougnet C, Landay AL, Rugeles MT. 2006. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol 120(2):138-146.
33. Moraes MP, de los Santos T, Koster M, Turecek T, Wang H, Andreyev VG, Grubman MJ. 2007. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J Virol 81(13):7124-7135.
34. Naume B, Gately M, Espevik T. 1992. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 148(8):2429-2436.
35. Neff S, Sa-Carvalho D, Rieder E, Mason PW, Blystone SD, Brown EJ, Baxt B. 1998. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol 72(5):3587-3594.
36. Nfon CK, Ferman GS, Toka FN, Gregg DA, Golde WT. 2008. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol 21(1):68-77.
37. Ochi M, Ohdan H, Mitsuta H, Onoe T, Tokita D, Hara H, Ishiyama K, Zhou W, Tanaka Y, Asahara T. 2004. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 39(5):1321-1331.
38. Perussia B, Chan SH, D'Andrea A, Tsuji K, Santoli D, Pospisil M, Young D, Wolf SF, Trinchieri G. 1992. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol 149(11):3495-3502.
39. Pescovitz MD, Lowman MA, Sachs DH. 1988. Expression of T-cell associated antigens by porcine natural killer cells. Immunology 65(2):267-271.
40. Pintaric M, Gerner W, Saalmuller A. 2008. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells. Vet Immunol Immunopathol 121(1-2):68-82.
41. Pinto A, Ferguson F. 1988. Characteristics of yorkshire swine natural killer cells. Vet Immunol Immunopathol 20(1):15-29.
42. Price GB, Teh HS, Miller RG. 1980. Specific spontaneous cytotoxic activity in human T cell colonies. J Immunol 124(5):2352-2355.
43. Richerson JT, Misfeldt ML. 1989. Host environment as a modulating factor of swine natural killer cell activity. Vet Immunol Immunopathol 23(3-4):309-319.
44. Rieder E, Berinstein A, Baxt B, Kang A, Mason PW. 1996. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus. Proc Natl Acad Sci USA 93(19):10428-10433.
45. Storset AK, Kulberg S, Berg I, Boysen P, Hope JC, Dissen E. 2004. NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics. Eur J Immunol 34(3):669-676.
46. Sutherland MA, Niekamp SR, Rodriguez-Zas SL, Salak-Johnson JL. 2006. Impacts of chronic stress and social status on various physiological and performance measures in pigs of different breeds. J Anim Sci 84(3):588-596.
47. Thale C, Kiderlen AF. 2005. Sources of interferon-gamma (IFN-gamma) in early immune response to Listeria monocytogenes. Immunobiology 210(9):673-683.